Interim report Q3 2025

Bactiguard Holding AB (publ) published its interim report for the third quarter on Thursday 23 October 2025 at 07:00 CET.

In connection with this, Bactiguard will host an audiocast for investors, analysts, and media at 11:00 CET. CEO Christine Lind will present the report and answer questions together with CFO Patrick Bach.

Updated strategic and financial targets

Bactiguard Holding AB (publ.) has announced its updated strategic and financial targets following a review announced in connection with the 2024 Q3 report. The updated targets reflect a sharpened strategic focus on the license business and EBITDA profitability, a transformation delivered in 2024.

The Bactiguard Technology

The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.

Purpose

To champion a healthier world by preventing infections.

Vision

To be the global standard of care for preventing medical device related infections.

Mission

To be the premier partner for leading MedTech companies, joining forces to redefine healthcare and improve health worldwide.

Core values

  • Respect
  • Trust
  • Transparency
  • Performance

Bactiguard is a purpose-driven company with a strong corporate culture, firmly anchored in four core values. The values are an integral part of Bactiguard’s purpose to champion a healthier world by preventing infections and a prerequisite to achieve our targets.

Bactiguard as an investment

The ambition is to become a profitable knowledge and specialist organization which is a prerequisite to deliver on our financial, strategic and sustainability targets.

  • 07
    Jan 2026

    Bactiguard presents at SEB Nordic Seminar

    Copenhagen, Denmark
  • 05
    Feb 2026

    Year-end report 1 January – 31 December 2025

  • 11
    Mar 2026

    Bactiguard presents at DNB Carnegie Nordic Healthcare Conference

    Stockholm, Sweden

Media & Investor Relations

  • Patrick Bach

    Patrick Bach

    CFO

    +46 (0) 76 129 59 11